Biotechnology and Patents: Global Standards, European Approaches and National Accents

GENETIC ENGINEERING AND THE WORLD TRADE SYSTEM, Daniel Wüger, Thomas Cottier, eds., Cambridge University Press, pp. 77-108, 2008

17 Pages Posted: 4 Dec 2010

See all articles by Geertrui Van Overwalle

Geertrui Van Overwalle

KU Leuven - Centre for IT & IP Law (CiTiP)

Date Written: 2008

Abstract

Intellectual property rights have, from their inception, been shaped by international treaties. National legislators have had to look at the international scene to gain some insight into the prevailing intellectual property standards. This trend was less prominent in the field of patent law and it was only with the coming into effect of the TRIPS Agreement that key international standards with regard to patents were established. In that regard, TRIPS seemed to constitute einen Meilenstein von enormer Bedeutung, (a major milestone) since, for the first time in patent history, it introduced a worldwide framework of minimum standards with regard to the grant, scope and use of patent rights.

The present paper describes the global standards for the patenting of biotechnological inventions and offers an in-depth and critical comparison against those of European and national regimes. Chapter 1 describes the TRIPS rules for the patenting of biotechnological inventions and hereby centres on six key issues: plants and animals, the human body, ethics, human rights, traditional knowledge and health. Chapter 2 examines the European patent biotech framework and revolves around the same topics. It will be seen that this examination demonstrates clearly that European patent law has adapted itself to the new reality of biotechnology in many ways, but that various issues remain unsettled and so call for further reflection and debate. In Chapter 3, a number of national patent systems for biotechnological inventions are considered, focusing on the same six topics. This review reveals that it comes as a real challenge for European Union Member States’ legislators to reconcile international or European objectives and national aspirations when adapting their patent laws to the new technology of genetic engineering.

Keywords: Patents, TRIPs, Biotechnological inventions, Human body, Ethics, Morality, Human rights, Traditional Knowledge, Health

JEL Classification: D23, D45, H 41, H51, I18, K11, L14, L 65, O13, O31, O32, O34

Suggested Citation

Van Overwalle, Geertrui, Biotechnology and Patents: Global Standards, European Approaches and National Accents (2008). GENETIC ENGINEERING AND THE WORLD TRADE SYSTEM, Daniel Wüger, Thomas Cottier, eds., Cambridge University Press, pp. 77-108, 2008, Available at SSRN: https://ssrn.com/abstract=1719208

Geertrui Van Overwalle (Contact Author)

KU Leuven - Centre for IT & IP Law (CiTiP) ( email )

Sint-Michielsstraat 6 box 3443
Leuven, 3000
Belgium

HOME PAGE: https://www.law.kuleuven.be/citip/en/staff/00015469

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
289
Abstract Views
1,876
Rank
192,249
PlumX Metrics